$TBPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Theravance Biopharma, Inc.. Get notifications about new insider transactions in Theravance Biopharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 33.78 | 10,030 | 338,813 | 162,347 | 172.4 K to 162.3 K (-5.82 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP Global Head Acu ... | Payment of Exercise | F | 33.78 | 8,762 | 295,980 | 219,118 | 227.9 K to 219.1 K (-3.85 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 33.78 | 9,611 | 324,660 | 225,071 | 234.7 K to 225.1 K (-4.10 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 33.78 | 10,138 | 342,462 | 170,490 | 180.6 K to 170.5 K (-5.61 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 33.78 | 14,434 | 487,581 | 177,471 | 191.9 K to 177.5 K (-7.52 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 33.78 | 10,211 | 344,928 | 226,350 | 236.6 K to 226.4 K (-4.32 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 9,000 | 0 | 184,332 | 175.3 K to 184.3 K (+5.13 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 903,399 | 875.4 K to 903.4 K (+3.20 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 9,000 | 0 | 200,722 | 191.7 K to 200.7 K (+4.69 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 9,000 | 0 | 172,377 | 163.4 K to 172.4 K (+5.51 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP Global Head Acu ... | Grant | A | 0.00 | 9,000 | 0 | 227,880 | 218.9 K to 227.9 K (+4.11 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Grant | A | 0.00 | 9,000 | 0 | 180,628 | 171.6 K to 180.6 K (+5.24 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 9,000 | 0 | 191,905 | 182.9 K to 191.9 K (+4.92 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 9,000 | 0 | 236,561 | 227.6 K to 236.6 K (+3.95 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 31.96 | 2,104 | 67,244 | 175,332 | 177.4 K to 175.3 K (-1.19 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 31.96 | 8,360 | 267,186 | 875,399 | 883.8 K to 875.4 K (-0.95 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 31.96 | 4,008 | 128,096 | 191,722 | 195.7 K to 191.7 K (-2.05 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 31.96 | 1,727 | 55,195 | 163,377 | 165.1 K to 163.4 K (-1.05 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 31.96 | 3,785 | 120,969 | 234,682 | 238.5 K to 234.7 K (-1.59 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 31.96 | 1,845 | 58,966 | 171,628 | 173.5 K to 171.6 K (-1.06 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 31.96 | 5,388 | 172,200 | 182,905 | 188.3 K to 182.9 K (-2.86 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 31.96 | 4,628 | 147,911 | 227,561 | 232.2 K to 227.6 K (-1.99 %) |
Aug 25 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 27.99 | 4,491 | 125,703 | 188,293 | 192.8 K to 188.3 K (-2.33 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 27.89 | 2,104 | 58,681 | 177,436 | 179.5 K to 177.4 K (-1.17 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 27.89 | 1,729 | 48,222 | 165,104 | 166.8 K to 165.1 K (-1.04 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 27.89 | 3,785 | 105,564 | 238,467 | 242.3 K to 238.5 K (-1.56 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 27.89 | 1,846 | 51,485 | 173,473 | 175.3 K to 173.5 K (-1.05 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 27.89 | 4,607 | 128,489 | 192,784 | 197.4 K to 192.8 K (-2.33 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 27.97 | 9,509 | 265,967 | 197,391 | 206.9 K to 197.4 K (-4.60 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.89 | 4,306 | 120,094 | 232,189 | 236.5 K to 232.2 K (-1.82 %) |
Aug 22 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 27.16 | 37,078 | 1,007,038 | 195,730 | 232.8 K to 195.7 K (-15.93 %) |
Aug 22 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 27.89 | 4,008 | 111,783 | 232,808 | 236.8 K to 232.8 K (-1.69 %) |
Aug 22 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 28.14 | 4,870 | 137,042 | 236,816 | 241.7 K to 236.8 K (-2.02 %) |
Aug 22 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 28.55 | 7,174 | 204,818 | 241,686 | 248.9 K to 241.7 K (-2.88 %) |
May 24 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 20.55 | 2,105 | 43,258 | 179,540 | 181.6 K to 179.5 K (-1.16 %) |
May 24 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 20.55 | 4,008 | 82,364 | 248,860 | 252.9 K to 248.9 K (-1.59 %) |
May 24 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 20.55 | 1,728 | 35,510 | 166,833 | 168.6 K to 166.8 K (-1.03 %) |
May 24 2016 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 20.55 | 3,785 | 77,782 | 242,252 | 246 K to 242.3 K (-1.54 %) |
May 24 2016 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 20.55 | 1,846 | 37,935 | 175,319 | 177.2 K to 175.3 K (-1.04 %) |
May 24 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 20.55 | 4,608 | 94,694 | 206,900 | 211.5 K to 206.9 K (-2.18 %) |
May 24 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 20.55 | 3,333 | 68,493 | 236,495 | 239.8 K to 236.5 K (-1.39 %) |
May 05 2016 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Grant | A | 0.00 | 6,000 | 0 | 29,059 | 23.1 K to 29.1 K (+26.02 %) |
May 05 2016 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 29,124 | 23.1 K to 29.1 K (+25.95 %) |
May 05 2016 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 6,000 | 0 | 178,392 | 172.4 K to 178.4 K (+3.48 %) |
May 05 2016 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 15,428 | 9.4 K to 15.4 K (+63.64 %) |
May 05 2016 | TBPH | Theravance Biophar ... | O'Connor Donal | Director | Grant | A | 0.00 | 6,000 | 0 | 9,000 | 3 K to 9 K (+200.00 %) |
May 05 2016 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
May 05 2016 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
May 05 2016 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Grant | A | 0.00 | 6,000 | 0 | 26,571 | 20.6 K to 26.6 K (+29.17 %) |
May 05 2016 | TBPH | Theravance Biophar ... | Fore Henrietta | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
May 05 2016 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 90,000 | 0 | 238,125 | 148.1 K to 238.1 K (+60.76 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 90,000 | 0 | 211,508 | 121.5 K to 211.5 K (+74.07 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Grant | A | 0.00 | 105,000 | 0 | 177,165 | 72.2 K to 177.2 K (+145.50 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 90,000 | 0 | 244,335 | 154.3 K to 244.3 K (+58.31 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Grant | A | 0.00 | 90,000 | 0 | 288,111 | 198.1 K to 288.1 K (+45.43 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | Sr. VP, Operations | Grant | A | 0.00 | 90,000 | 0 | 217,178 | 127.2 K to 217.2 K (+70.77 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 105,000 | 0 | 168,561 | 63.6 K to 168.6 K (+165.20 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 115,000 | 0 | 251,165 | 136.2 K to 251.2 K (+84.46 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 280,000 | 0 | 882,056 | 602.1 K to 882.1 K (+46.51 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 105,000 | 0 | 179,943 | 74.9 K to 179.9 K (+140.11 %) |
Mar 15 2016 | TBPH | Theravance Biophar ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 23,028,000.00 | 1,301,015 | 29,959,728,534,982 | 9,644,807 | 8.3 M to 9.6 M (+15.59 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 15.65 | 18,920 | 296,098 | 136,165 | 155.1 K to 136.2 K (-12.20 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 15.65 | 13,052 | 204,264 | 148,125 | 161.2 K to 148.1 K (-8.10 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 15.65 | 19,844 | 310,559 | 198,111 | 218 K to 198.1 K (-9.10 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 15.65 | 16,049 | 251,167 | 154,335 | 170.4 K to 154.3 K (-9.42 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Payment of Exercise | F | 15.65 | 18,425 | 288,351 | 121,508 | 139.9 K to 121.5 K (-13.17 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 15.65 | 16,101 | 251,981 | 182,731 | 198.8 K to 182.7 K (-8.10 %) |
Feb 23 2016 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | Sr. VP, Operations | Payment of Exercise | F | 15.65 | 10,830 | 169,490 | 127,178 | 138 K to 127.2 K (-7.85 %) |
Nov 24 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 17.17 | 934 | 16,037 | 155,085 | 156 K to 155.1 K (-0.60 %) |
Nov 24 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 17.17 | 934 | 16,037 | 217,955 | 218.9 K to 218 K (-0.43 %) |
Nov 24 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 17.17 | 1,037 | 17,805 | 170,384 | 171.4 K to 170.4 K (-0.60 %) |
Nov 24 2015 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Payment of Exercise | F | 17.17 | 781 | 13,410 | 139,933 | 140.7 K to 139.9 K (-0.56 %) |
Oct 23 2015 | TBPH | Theravance Biophar ... | O'Connor Donal | Director | Option Exercise | A | 13.57 | 12,000 | 162,840 | 12,000 | |
Oct 23 2015 | TBPH | Theravance Biophar ... | O'Connor Donal | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Oct 07 2015 | TBPH | Theravance Biophar ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 607,544.00 | 44,574 | 27,080,649,318 | 8,343,792 | 8.3 M to 8.3 M (+0.54 %) |
Aug 24 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 12.98 | 934 | 12,123 | 218,889 | 219.8 K to 218.9 K (-0.42 %) |
Aug 24 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 12.98 | 934 | 12,123 | 198,832 | 199.8 K to 198.8 K (-0.47 %) |
Aug 24 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 12.98 | 934 | 12,123 | 156,019 | 157 K to 156 K (-0.60 %) |
Aug 18 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Buy | P | 12.90 | 9,000 | 116,100 | 9,000 | 0 to 9 K |
Aug 18 2015 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Buy | P | 12.92 | 10,000 | 129,200 | 20,571 | 10.6 K to 20.6 K (+94.60 %) |
Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.16 | 5,000 | 60,800 | 161,177 | 156.2 K to 161.2 K (+3.20 %) |
Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.19 | 5,000 | 60,950 | 154,279 | 149.3 K to 154.3 K (+3.35 %) |
Aug 17 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 12.13 | 16,860 | 204,512 | 602,056 | 585.2 K to 602.1 K (+2.88 %) |
Aug 17 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 11.79 | 63,140 | 744,421 | 583,298 | 520.2 K to 583.3 K (+12.14 %) |
Jun 04 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 13.83 | 7,360 | 101,789 | 156,953 | 164.3 K to 157 K (-4.48 %) |
Jun 04 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 13.83 | 7,360 | 101,789 | 219,823 | 227.2 K to 219.8 K (-3.24 %) |
Jun 04 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 13.83 | 5,152 | 71,252 | 169,720 | 174.9 K to 169.7 K (-2.95 %) |
Jun 04 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 13.83 | 7,360 | 101,789 | 199,766 | 207.1 K to 199.8 K (-3.55 %) |
May 22 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 14.24 | 673 | 9,584 | 164,313 | 165 K to 164.3 K (-0.41 %) |
May 22 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 14.24 | 748 | 10,652 | 174,872 | 175.6 K to 174.9 K (-0.43 %) |
May 22 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 14.24 | 673 | 9,584 | 207,126 | 207.8 K to 207.1 K (-0.32 %) |
May 22 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 14.24 | 673 | 9,584 | 227,183 | 227.9 K to 227.2 K (-0.30 %) |
Apr 24 2015 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Apr 24 2015 | TBPH | Theravance Biophar ... | Fore Henrietta | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Apr 24 2015 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Apr 24 2015 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 18.41 | 12,000 | 220,920 | 12,000 | |
Apr 24 2015 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Apr 24 2015 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Grant | A | 0.00 | 6,000 | 0 | 33,906 | 27.9 K to 33.9 K (+21.50 %) |
Apr 24 2015 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Grant | A | 0.00 | 6,000 | 0 | 10,571 | 4.6 K to 10.6 K (+131.26 %) |
Apr 24 2015 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 9,428 | 3.4 K to 9.4 K (+175.03 %) |
Apr 24 2015 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 6,000 | 0 | 221,054 | 215.1 K to 221.1 K (+2.79 %) |
Apr 24 2015 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 23,124 | 17.1 K to 23.1 K (+35.04 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 19.52 | 674 | 13,156 | 163,088 | 163.8 K to 163.1 K (-0.41 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 19.52 | 674 | 13,156 | 227,856 | 228.5 K to 227.9 K (-0.29 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 19.52 | 970 | 18,934 | 175,620 | 176.6 K to 175.6 K (-0.55 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 19.52 | 674 | 13,156 | 207,799 | 208.5 K to 207.8 K (-0.32 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 19.52 | 1,480 | 28,890 | 520,158 | 521.6 K to 520.2 K (-0.28 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 135,000 | 0 | 149,279 | 14.3 K to 149.3 K (+945.44 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 120,000 | 0 | 163,762 | 43.8 K to 163.8 K (+274.21 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Grant | A | 0.00 | 130,000 | 0 | 228,530 | 98.5 K to 228.5 K (+131.94 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | Sr. VP, Operations | Grant | A | 0.00 | 130,000 | 0 | 135,714 | 5.7 K to 135.7 K (+2,275.11 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 110,000 | 0 | 176,590 | 66.6 K to 176.6 K (+165.19 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Grant | A | 0.00 | 135,000 | 0 | 140,714 | 5.7 K to 140.7 K (+2,362.62 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 90,000 | 0 | 208,473 | 118.5 K to 208.5 K (+75.97 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | W | 0.00 | 57 | 0 | 521,638 | 521.6 K to 521.6 K (+0.01 %) |
Feb 09 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 250,000 | 0 | 521,581 | 271.6 K to 521.6 K (+92.05 %) |
Nov 24 2014 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 0.00 | 657 | 0 | 53,962 | 54.6 K to 54 K (-1.20 %) |
Nov 24 2014 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 0.00 | 658 | 0 | 80,492 | 81.2 K to 80.5 K (-0.81 %) |
Nov 24 2014 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 0.00 | 660 | 0 | 25,724 | 26.4 K to 25.7 K (-2.50 %) |
Oct 10 2014 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Option Exercise | A | 22.00 | 170,000 | 3,740,000 | 170,000 | |
Oct 10 2014 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | A | 22.00 | 170,000 | 3,740,000 | 170,000 | |
Sep 10 2014 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Option Exercise | A | 28.75 | 170,000 | 4,887,500 | 170,000 | |
Sep 10 2014 | TBPH | Theravance Biophar ... | Shafer Bradford J | Sr VP, Gen. Counsel ... | Option Exercise | A | 28.75 | 170,000 | 4,887,500 | 170,000 | |
Aug 26 2014 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Option Exercise | A | 28.35 | 320,000 | 9,072,000 | 320,000 | |
Aug 22 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Payment of Exercise | F | 26.98 | 158 | 4,263 | 14,279 | 14.4 K to 14.3 K (-1.09 %) |
Jul 23 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Option Exercise | A | 32.13 | 85,000 | 2,731,050 | 85,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Option Exercise | A | 23.51 | 80,000 | 1,880,800 | 80,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | Sr. Vice President, ... | Option Exercise | A | 23.51 | 100,000 | 2,351,000 | 100,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | VP-Clinical Develop ... | Option Exercise | A | 23.51 | 59,375 | 1,395,906 | 59,375 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | JONKER JEFFREY DAVID | Senior VP, Corp. & ... | Option Exercise | A | 23.51 | 123,100 | 2,894,081 | 123,100 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | VP-Finance | Option Exercise | A | 23.51 | 85,000 | 1,998,350 | 85,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | Fore Henrietta | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | Fore Henrietta | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | ATIEH MICHAEL G | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 | |
Jun 05 2014 | TBPH | Theravance Biophar ... | ATIEH MICHAEL G | Director | Option Exercise | A | 23.51 | 12,000 | 282,120 | 12,000 |